Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
We believe that laparoscopic distal pancreatectomy for cancer allows quicker recovery and
significantly reduces the chances of postoperative wound breakdown. This will shorten the
wait time required to begin adjuvant therapy to one week after surgery thereby combating the
micrometastasis unseen at the time of surgery. Prognosis for patients with pancreatic cancer
will therefore improve along with decreasing the incidence of locoregional recurrence.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins